1.	Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients Phase: Phase IV Type: Supportive care Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 100943, NCT00195533
2.	Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count Phase: Phase III Type: Supportive care Status: Completed Age: 2 and over Sponsor: Other Protocol IDs: EORTC-46971, NCT00003805
3.	Phase III MOX/AMK vs MOX/PIP for Suspected Infection in Febrile, Granulocytopenic Cancer Patients, with Amphotericin-B or Ketoconazole for Failures Phase: Phase III Type: Supportive care Status: Closed Age: no age specified Sponsor: Protocol IDs: UMCC-8107
4.	Phase III Randomized Study of Initial Empiric Antimicrobial Therapy with TMP-SMX/Erythromycin and Other Antibiotics as Indicated vs Pretreatment Bronchoalveolar Lavage and Pathogen-Specific Therapy in Immunocompromised Patients with Diffuse Interstitial Pneumonitis (Summary last modified 06/97) Phase: Phase III Type: Supportive care Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: NCI-86-C-26, NCI-T86-0081N, T86-0081
5.	Phase II Management of Fever and Infection in Cancer Patients --- Fever Study IV (Summary Last Modified 06/97) Phase: Phase II Type: Supportive care Status: Completed Age: any age Sponsor: NCI Protocol IDs: NCI-85-C-212C, NCI-T86-0036N, T86-0036
6.	Piperacillin/Gentamicin vs Ticarcillin/Gentamicin for Suspected Infection in Febrile, Granulocytopenic Cancer Patients Phase: No phase specified Type: Supportive care Status: Closed Age: no age specified Sponsor: Protocol IDs: UMCC-7805
7.	Randomized Study of Parenteral Piperacillin/Tazobactam plus Amikacin vs Parenteral Ceftazidime plus Amikacin in the Treatment of Febrile, Granulocytopenic Cancer Patients (Summary Last Modified 12/91) Phase: No phase specified Type: Supportive care Status: Completed Age: 2 months and over Sponsor: Protocol IDs: EORTC-46911